A detailed history of Jacobs Levy Equity Management, Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 2,108,544 shares of FGEN stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,108,544
Previous 2,104,901 0.17%
Holding current value
$1.01 Million
Previous $1.87 Million 54.99%
% of portfolio
0.0%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.33 - $1.26 $1,202 - $4,590
3,643 Added 0.17%
2,108,544 $843,000
Q2 2024

Aug 14, 2024

SELL
$0.89 - $2.36 $91,409 - $242,388
-102,707 Reduced 4.65%
2,104,901 $1.87 Million
Q1 2024

May 15, 2024

SELL
$0.73 - $2.73 $205,785 - $769,581
-281,898 Reduced 11.32%
2,207,608 $5.19 Million
Q4 2023

Feb 14, 2024

SELL
$0.38 - $0.91 $25,696 - $61,536
-67,622 Reduced 2.64%
2,489,506 $2.22 Million
Q3 2023

Nov 16, 2023

BUY
$0.79 - $2.83 $1.23 Million - $4.41 Million
1,559,903 Added 156.42%
2,557,128 $2.2 Million
Q2 2023

Aug 14, 2023

SELL
$2.49 - $20.59 $303,553 - $2.51 Million
-121,909 Reduced 10.89%
997,225 $2.69 Million
Q1 2023

May 15, 2023

SELL
$15.95 - $25.18 $4.9 Million - $7.74 Million
-307,503 Reduced 21.55%
1,119,134 $20.9 Million
Q4 2022

Feb 14, 2023

SELL
$13.27 - $17.73 $51,607 - $68,951
-3,889 Reduced 0.27%
1,426,637 $22.9 Million
Q3 2022

Nov 15, 2022

SELL
$11.4 - $14.6 $309,532 - $396,419
-27,152 Reduced 1.86%
1,430,526 $18.6 Million
Q2 2022

Aug 15, 2022

SELL
$7.94 - $12.96 $72,484 - $118,311
-9,129 Reduced 0.62%
1,457,678 $15.4 Million
Q1 2022

May 16, 2022

BUY
$12.02 - $16.79 $966,251 - $1.35 Million
80,387 Added 5.8%
1,466,807 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$9.93 - $15.39 $3.84 Million - $5.95 Million
386,654 Added 38.67%
1,386,420 $19.5 Million
Q3 2021

Nov 15, 2021

BUY
$10.18 - $26.64 $227,940 - $596,496
22,391 Added 2.29%
999,766 $10.2 Million
Q2 2021

Aug 16, 2021

BUY
$18.57 - $35.68 $17.4 Million - $33.4 Million
935,402 Added 2228.58%
977,375 $26 Million
Q1 2021

May 17, 2021

SELL
$31.0 - $55.72 $2.49 Million - $4.48 Million
-80,316 Reduced 65.68%
41,973 $1.46 Million
Q4 2020

Feb 16, 2021

SELL
$37.09 - $48.97 $2.63 Million - $3.47 Million
-70,840 Reduced 36.68%
122,289 $4.54 Million
Q3 2020

Nov 16, 2020

BUY
$40.47 - $45.5 $7.82 Million - $8.79 Million
193,129 New
193,129 $7.94 Million
Q2 2020

Aug 17, 2020

SELL
$32.57 - $42.83 $3.78 Million - $4.97 Million
-115,995 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $1.84 Million - $3.62 Million
-78,831 Reduced 40.46%
115,995 $4.03 Million
Q4 2019

Feb 14, 2020

BUY
$34.58 - $48.06 $1.48 Million - $2.06 Million
42,760 Added 28.12%
194,826 $8.36 Million
Q3 2019

Nov 14, 2019

BUY
$36.98 - $48.45 $695,223 - $910,860
18,800 Added 14.11%
152,066 $5.62 Million
Q2 2019

Aug 13, 2019

BUY
$35.13 - $55.53 $4.68 Million - $7.4 Million
133,266 New
133,266 $6.02 Million
Q3 2017

Nov 14, 2017

SELL
$33.4 - $53.9 $2.95 Million - $4.76 Million
-88,314 Closed
0 $0
Q2 2017

Nov 09, 2017

BUY
N/A
88,314
88,314 $2.85 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $45M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.